BamSEC and AlphaSense Join Forces
Learn More

Grace Therapeutics Inc.

NASDAQ: GRCE    
Share price (1/7/25): $4.22    
Market cap (1/7/25): $42.8 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2024
Other Revised 11/20/24 Grace Therapeutics, Inc. - Special Call 11/20/24
CY 2023
Other Revised 10/11/23 Acasti Pharma Inc. - Special Call 10/11/23 Other Revised 10/10/23 Acasti Pharma Inc. - Shareholder/Analyst Call 10/10/23 Earnings Revised 02/14/23 Acasti Pharma Inc., Q3 2023 Earnings Call, Feb 14, 2023 02/14/23 Other Revised 01/10/23 Acasti Pharma Inc. - Special Call 01/10/23
CY 2022
Earnings Revised 11/14/22 Acasti Pharma Inc., Q2 2023 Earnings Call, Nov 14, 2022 11/14/22 Earnings Revised 08/11/22 Acasti Pharma Inc., Q1 2023 Earnings Call, Aug 11, 2022 08/11/22 Earnings Revised 06/21/22 Acasti Pharma Inc., 2022 Earnings Call, Jun 21, 2022 06/21/22 Other Revised 05/18/22 Acasti Pharma Inc. - Special Call 05/18/22 Earnings Revised 02/14/22 Acasti Pharma Inc., Q3 2022 Earnings Call, Feb 14, 2022 02/14/22
CY 2021
Earnings Revised 11/10/21 Acasti Pharma Inc., Q2 2022 Earnings Call, Nov 10, 2021 11/10/21 Other Revised 08/04/21 Acasti Pharma Inc., Grace Therapeutics, Inc. - M&A Call 08/04/21
CY 2020
Other Revised 09/30/20 Acasti Pharma Inc. - Shareholder/Analyst Call 09/30/20 Earnings Revised 06/29/20 Acasti Pharma Inc., 2020 Earnings Call, Jun 29, 2020 06/29/20 Earnings Revised 02/14/20 Acasti Pharma Inc., Q3 2020 Earnings Call, Feb 14, 2020 02/14/20
CY 2019
Earnings Revised 11/13/19 Acasti Pharma Inc., Q2 2020 Earnings Call, Nov 13, 2019 11/13/19 Earnings Revised 08/14/19 Acasti Pharma Inc., Q1 2020 Earnings Call, Aug 14, 2019 08/14/19 Earnings Revised 06/26/19 Acasti Pharma Inc., Q4 2019 Earnings Call, Jun 26, 2019 06/26/19